Cancer Clinical Pharmacy 3

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/64

encourage image

There's no tags or description

Looks like no tags are added yet.

65 Terms

1
New cards

Which cells are most at risk of damage by non-specific chemotherapy agents?

cells which have a high turnover (i.e. divide the most rapidly)

E.g. mucosal lining of the GI tract

E.g. hair follicles

E.g. blood cells

2
New cards

Side effects of chemotherapy based on the type of cell affected

Mucosal lining of the GI tract - diarrhoea and vomiting

Hair follicles - alopecia

Blood cells - anaemia and neutropenia

3
New cards

Nausea and Vomiting

3 phases of nausea and vomiting

  • Acute - occurs following chemotherapy

  • Decayed - occurs following chemotherapy

  • Anticipatory - occurs prior to chemotherapy


4
New cards

Nausea and Vomiting

Acute nausea and vomiting

Occurs during the first 24 hours immediately after chemotherapy

5
New cards

Nausea and Vomiting

Delayed nausea and vomiting

Occurs between 24 hours and up to 6/7 days later

6
New cards

Nausea and Vomiting

Anticipatory nausea and vomiting

A conditioned response where a patient experiences nausea or vomiting before a chemotherapy treatment session even begins

7
New cards

Nausea and Vomiting

Effects of uncontrolled nausea and vomiting

  • Reduced quality of life for the patient

  • Dehydration

  • If N+V becomes problematic, the only way to administer other medications is via a subcutaneous syringe driver

  • Admission to hospital

  • Dose reductions of chemotherapy

  • Patient may refuse treatment


8
New cards

Nausea and Vomiting

What needs to be ensured within a chemotherapy combination regimen?

Ensure there is not 2 or more agents with particularly pronounced nausea and vomiting

9
New cards

Anti-emetics

Anti-emetic guidelines for prophylaxis of chemotherapy and radiotherapy induced nausea and vomiting

knowt flashcard image
10
New cards
<p><u>Anti-emetics</u></p><p>What is the difference between the 2 high risk emetogenic potential categories?</p>

Anti-emetics

What is the difference between the 2 high risk emetogenic potential categories?

  1. If patient taking an anthracycline + cyclophosphamide OR cisplatin at a dose of 70/m2 or more » considered high risk and acrepitant is indicated


  1. If patient is NOT taking anthracycline + cyclophosphamide OR cisplatin at a dose of 70/m2 or more » acrepitant is not indicated


11
New cards

Anti-emetics

Acrepitant

  • NK1 inhibitor

  • Fosacrepitant is the salt of acrepitant that can be administered intravenously

  • Acrepitant is only licensed to be used in conjunction with dexamethasone and a 5-HT3 antagonist

  • Where an Acrepitant is used as part of an anti-emetic regimen (top row high risk emotogenic potential), dexamethasone dose is reduced


12
New cards
<p><u>Anti-emetics</u></p><p>How do we determine the emetic risk of chemotherapy?</p>

Anti-emetics

How do we determine the emetic risk of chemotherapy?

Example:

  • A chemotherapy regimen of Carboplatin (dose: 5AUC) with Cetuximab

  • Carboplatin >= 4AUC = high emesis risk

  • Cetuximab = low emesis risk

  • Go with the highest causing risk

  • This regimen has a high emetic risk. This determines which anti-emetic we prescribe


Example:

  • A chemotherapy regimen consisting of 2 drugs with a moderate emetic risk

  • This regimen has a high emetic risk


<p><u>Example:</u></p><ul><li><p>A chemotherapy regimen of <mark data-color="green" style="background-color: green; color: inherit;">Carboplatin (dose: 5AUC)</mark> with <mark data-color="green" style="background-color: green; color: inherit;">Cetuximab</mark></p></li><li><p>Carboplatin &gt;= 4AUC = <strong>high emesis risk</strong></p></li><li><p>Cetuximab = <strong>low emesis risk</strong></p></li><li><p>Go with the highest causing risk </p></li><li><p><strong>This regimen has a high emetic risk. This determines which anti-emetic we prescribe </strong></p></li></ul><p></p><p><u>Example:</u></p><ul><li><p>A chemotherapy regimen consisting of <strong>2 drugs with a moderate emetic risk</strong></p></li><li><p><strong>This regimen has a high emetic risk </strong></p></li></ul><p></p>
13
New cards

Diarrhoea

Main chemotherapy agents associated with diarrhoea

  • Capecitabine

  • Irinotecan

  • Tyrosine kinase inhibitors e..g imatinib

  • Immunotherapy


14
New cards

Diarrhoea

Treatment

  • Loperamide (except in immunotherapy patients)

  • Oral rehydration therapy

  • Codeine (added to / to replace loperamide)

  • Ocreotide (somatostatin analogue, reduces intestinal motility)

  • Atropine (given prophylactically in regimens containing irinotecan)


15
New cards

Diarrhoea

When is ocreotide only used?

  • If loperamide is ineffective

  • In grade 3 - 4 diarrheoa


16
New cards

Diarrhoea

When is atropine used?

given prophylactically in regimens containing irinotecan


17
New cards

Mucositis

What causes mucositis?

Damage to the mucosal lining of the GI tract

18
New cards

Mucositis

Main chemotherapy agents associated with mucositis?

  • Flourouracil - particularly when it is given as a continuous infusion

  • Capecitabine

  • Methotrexate (high dose)


19
New cards

Mucositis

Problems associated with mucositis

  • Difficult for patients to look after their gums and maintain good oral hygiene, risk of cutting gums when brushing teeth - so risk of infection

  • Decreases oral intake - in severe cases: patients may require IV fluids, patients may be prescribed total parenteral nutrition

  • Pain


20
New cards

Mucositits

Recommendations to prevent mucositis

  • Use a soft toothbrush

  • Maintain good oral hygeine

  • Use a mouthwash to reduce risk of infection e.g. Corsodyl, Nystatin


21
New cards

Mucositis

Treatment

  • Difflam mouthwash - steroid containing mouthwash, reduces inflammation

  • Sucralfate mouthwash - able to swallow so coats the mouth and oesophagus

  • Lignocaine mouthwash - local anaesthetic that numbs any pain, however can make it difficult for patients to feel food while eating which can lead to gum or lip cuts

  • Paracetamol

  • Severe cases: morphine, dose reductions

  • Palifermin - human keratinocyte growth factor, not widely available on the NHS, normally used for bone marrow transplant induced mucositis


22
New cards

Alopecia

Which chemotherapy agents are most associated with Alopecia?

  • Not all chemotherapy agents cause alopecia


Most associated with:

  • Anti-microtubule agents e.g. taxanes, vincas

  • Anthracyclines

  • Methotrexate


23
New cards

Alopecia

Extent of chemotherapy induced Alopecia

  • Not necessarily complete hair loss - can be thinning of the hair

  • Not all hair on the body is lost

  • Happens gradually and reverses at the end of treatment


24
New cards

Alopecia

Advice to minimise hair loss

  • Avoid hair dye

  • Avoid perms

  • Avoid plaits

  • Avoid using hairdryers


25
New cards

Alopecia

Treatment

  • No pharmacological treatments available

  • However, can consider scalp cooling

    • 20 - 30 mins before chemotherapy

    • Cold liquid continuously circulates through a cap that is placed on the patient’s head

    • This reduces the surface temperature of the scalp, causing the capillaries around the hair follicles to constrict

    • This reduces blood supply to the hair follicle, so chemotherapy has less chance of reaching the hair follicle

    • This reduces chance of hair loss


26
New cards

Alopecia

What is a drawback of scalp cooling

  • Scalp cooling impacts the circulation of the chemotherapy

  • Cannot use scalp cooling if patient has a cancer that has spread to the CNS e.g. brain metastasis

  • Risk that constriction of the blood vessels will reduce impact of chemotherapy on the cancer in the CNS


27
New cards

Extravasation

What is extravasation?

  • Where a parenteral fluid goes into the subcutaneous tissue instead of the vein

  • Leakage of the fluid into the surrounding tissue can cause damage


28
New cards

Extravasation

What is important to consider if we suspect extravasation has occurred ?

  • Whether the chemotherapy agent is acidic or alkaline

  • Acidic or alkaline agents are more likely to cause damage

  • We check the SPC for each agent to determine the risk


29
New cards

Extravasation

How can extravasation be prevented?

  • Trained nurses

  • Using appropriate lines or cannulas

  • Assessing the appropriateness of the vein that the chemo is going into

    • Avoid administering fluids into the back of the hand as veins are smaller and less strong

    • Instead, use veins in the pit of the elbow


30
New cards

Extravasation

How long after treatment can extravasation occur?

During or a couple of hours after treatment

31
New cards

Extravasation

What is an important complication that extravasation can cause?

  • Tissue necrosis

  • Any signs of pain / burning

  • Needs to be treated ASAP


32
New cards

Extravasation

Categories of chemotherapy drugs based on their potential to cause harm if extravasation occurs

  1. Vesicants

  • Causes serious effects such as tissue necrosis if extravasation occurs

  • Further subdivided:

    • DNA-Binding - greatest potential for causing significant tissue damage (binds to DNA of healthy cells)

    • Non-DNA-Binding


  1. Irritants

  • Causes pain, redness or swelling but less likely to cause serious effects such as necrosis if extravasation occurs


  1. Non-vesicants

  • Low potential for causing harm if extravasation occurs



<ol><li><p><strong>Vesicants</strong></p></li></ol><ul><li><p>Causes serious effects such as <mark data-color="red" style="background-color: red; color: inherit;">tissue necrosis</mark> if extravasation occurs</p></li><li><p>Further subdivided:</p><ul><li><p>DNA-Binding - greatest potential for causing significant tissue damage (binds to DNA of healthy cells)</p></li><li><p>Non-DNA-Binding </p></li></ul></li></ul><p></p><ol start="2"><li><p><strong>Irritants</strong></p></li></ol><ul><li><p>Causes <mark data-color="yellow" style="background-color: yellow; color: inherit;">pain, redness or swelling</mark> but less likely to cause serious effects such as necrosis if extravasation occurs</p></li></ul><p></p><ol start="3"><li><p><strong>Non-vesicants</strong></p></li></ol><ul><li><p><mark data-color="green" style="background-color: green; color: inherit;">Low potential for causing harm</mark> if extravasation occurs</p></li></ul><p></p><p></p>
33
New cards

Laboratory Results

Which lab results should be monitored in patients undergoing chemotherapy?

  • Full Blood Counts (FBCs) - neutrophils, white blood cell count, platelets, Hb

  • Renal function - creatinine, urea

  • Hepatic function - LFTs

  • Cardiac function - echocardiogram to see LFEF

  • U & Es

  • Tumour biomarkers e.g. PSA levels


34
New cards

Laboratory Results

Example of chemo agent which can cause significant cardiac damage

Anthracyclines

35
New cards

Bone Marrow Suppression

Signs of reductions in red or white blood cell counts

  • Unexplained bleeding (thrombocytopenia)

  • Unexplained bruising (thrombocytopenia)

  • Sore throat (neutropenia)

  • Fever (neutropenia)

  • Fatigue (drop in Hb causing anaemia)

  • Breathlessness (drop in Hb causing anaemia)


36
New cards

Neutropenia

What is neutropenia?

A lower than normal level of neutrophils - neutrophils are a type of white blood cell

37
New cards

Neutropenia

Effect on treatment of neutrophil count is too low

Treatment is delayed

38
New cards

Neutropenia

2 types of neutropenia

  1. Neutropenic sepsis

  • Absolute neutrophil count of 0.5 × 109/L or lower

AND

  • Temperature of greater than 38°C AND any signs of sepsis



  1. Febrile neutropenia

  • Absolute neutrophil count of 0.5 × 109/L or lower

AND

  • Temperature of greater than 38°C but NO signs of sepsis


39
New cards

Neutropenia

Consequences of neutropenia

  • Medical emergency

  • Patient immediately admitted for broad-spectrum antibiotic therapy: piperacillin + tazobactam + gentamicin

  • Possibly consider granulocyte-colony stimulating factor (GCSF)


40
New cards

Neutropenia

Effects of GCSF

  • Stimulates production of neutrophils

  • Reduces duration of neutropenia and incidence of febrile neutropenia


41
New cards

Neutropenia

How can granulocyte-colony stimulating factor (GCSF) be used in relation to chemotherapy?

  1. Primary prevention of neutropenia

  • To prevent neutropenia from happening in the first place

  • E.g. for patients taking docetaxel or anthracyclines, GCSF is given automatically a few days after treatment



  1. Secondary prevention of neutropenia

  • For patients who develop neutropenia after chemotherapy treatment where no GCSF prophylaxis was originally used e.g. after stem-cell therapy

  • Patient is given the same dose of chemotherapy again BUT GCSF prescribed for secondary prevention of neutropenia


42
New cards

Thrombocytopenia

What is thrombocytopenia?

Reduced platelet count

43
New cards

Thrombocytopenia

Consequences of thrombocytopenia


  • Delays in treatment to allow platelet count to recover

  • Dose reductions


44
New cards

Thrombocytopenia

Treatment

  • If severe, patients can be given pools of platelets - however recovery in platelet count is short lived

  • Withdrawal of chemotherapy and cessation of any antiplatelets e.g. aspirin, LMWH is usually enough


45
New cards

Anaemia

What is anaemia?

Reduction in Hb levels

46
New cards

Anaemia

Symptoms

Fatigue, breathlessness

47
New cards

Anaemia

Frequency

Most chemo agents can cause anaemia

48
New cards

Anaemia

Treatment / Management

  • Iron tablets

  • Blood transfusions if Hb is critically low


49
New cards

Anaemia

Drawback of blood transfusions for treatment of anaemia

Some patients can become transfusion-dependent which can lead to iron overload

50
New cards

Tumour Lysis Syndrome

What is tumour lysis syndrome?

  • A metabolic syndrome

  • Malignant (cancer) cells break down

  • Causing intracellular contents to leak into the bloodstream


51
New cards

Tumour Lysis Syndrome

Signs

  • Hyperuricaemia (high uric acid)

  • Hyperphosphataemia

  • Hyperkalaemia

  • Hypocalcaemia


(Cell lysis leads to the release of electrolytes into the bloodstream)

52
New cards

Tumour Lysis Syndrome

Consequences

Change in electrolyte levels in the blood can lead to:

  • Renal damage

  • Arrhythmias

  • Seizures

  • Death


53
New cards

Tumour Lysis Syndrome

Which cancers is tumour lysis syndrome is most commonly associated with?

  • Cancers with high proliferation rates and tumour burden (‘bulky disease’)

    • Cancers that are fast growing are more likely to have more cells

    • Cancers that are larger are more likely to have more cells

  • So when the first cycle of chemotherapy is given, there is a higher risk of tumour lysis syndrome because the volume of cancer cells being impacted is the highest

  • More cancer cells being targeted by chemo = more cells are at risk of undergoing lysis


54
New cards

Tumour Lysis Syndrome

Cancers with a high proliferation and high tumour burden that are more at risk of tumour lysis syndrome

  • Hodgkin’s lymphoma

  • Acute myeloid leukaemia


55
New cards

Tumour Lysis Syndrome

Additional risk factors for tumour lysis syndrome?

  • Increasing age

  • Existing abnormal levels of electrolytes (uric acid, phosphate, potassium, calcium)

  • Impaired renal function - harder to clear electrolytes


56
New cards

Tumour Lysis Syndrome

Treatment / Management

  • Allopurinol

    • Xanthane oxidase inhibitor

    • Reduces production of uric acid (most problematic electrolyte imbalance)

    • This prevents uric acid crystallisation in the kidneys


  • Rasburicase

    • Urate from uric acid is metabolised by rasburicase into allantoin

    • Allantoin is more soluble than uric acid, which makes it easier for the body to eliminate


  • Management of hyperkalaemia

  • In extreme cases, dialysis is required


57
New cards

Tumour Lysis Syndrome

Example of ‘bulky disease’

knowt flashcard image
58
New cards

Haemorrhagic Cystitis

Which chemotherapy agents is this side effects most commonly associated with?

  • Cyclophosphamide

  • Ifosfamide


59
New cards

Haemorrhagic Cystitis

What causes haemorrhagic cystitis?

  • Cyclophosphamide is metabolised to produce acrolein

  • Acrolein can irritate the lining of the bladder

  • The lining of the bladder is then shed in the urine

  • This leads to haemorrhagic cystitis


60
New cards

Haemorrhagic Cystitis

Treatment

Mesna

  • Binds with acrolein in the kidneys, preventing damage to the bladder

  • Mensa is always given to patients receiving:

    • Cyclophosphamide doses of 1g/m2 (oral or iv

    • All doses ofifosfamide


61
New cards

Peripheral Neuropathy

Which chemotherapy agents is peripheral neuropathy most associated with?

  • Platinum agents

  • Capecitabine

  • Vincas


62
New cards

Peripheral Neuropathy

Symptoms

  • Change in sensation of fingertips / toes

  • Increased sensitivity

  • Pain

  • Numbness

  • Pins and needles

  • Muscle weakness

  • Difficulty handling small objects

  • Issues with balance, walking, co-ordination

  • Constipation and bloating


63
New cards

Peripheral Neuropathy

Management

Symptoms are treated as they occur rather than prevented:

  • Pyridoxine aka Vitamin B6 - 50mg PO TDS

  • Severe cases: Gabapentin or Pregabalin

  • Non pharmacological treatment: TENS, Acupuncture


64
New cards
<p><u>Plantar-Palmar Erythema (PPE)</u></p><p>Management</p>

Plantar-Palmar Erythema (PPE)

Management

  • Emollients - to reduce cracking, dryness

  • If severe: chemotherapy dose reduction


65
New cards

Cardiotoxicity

Management